Patents by Inventor Revital Lifshitz-Liron

Revital Lifshitz-Liron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing Cinacalcet hydrochloride
    Patent number: 7250533
    Abstract: Processes for preparing cinacalcet are provided.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: July 31, 2007
    Assignee: Teva Pharmaceutical Industries Ltd
    Inventors: Revital Lifshitz-Liron, Amihai Eisenstadt, Shlomit Wizel, Sharon Avhar-Maydan, Yuriy Raizi, Revital Ramaty
  • Processes for preparing cinacalcet hydrochloride crystal Form I
    Patent number: 7247751
    Abstract: The invention provides processes for the preparation of cinacalcet hydrochloride crystalline Form I.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: July 24, 2007
    Assignee: Teva Pharmaceutical Industries Ltd
    Inventors: Revital Lifshitz-Liron, Sharon Avhar-Maydan
  • Solid and crystalline ibandronic acid
    Publication number: 20070161606
    Abstract: Provided are novel crystalline and amorphous forms of ibandronic acid, methods for their preparation, and pharmaceutical compositions containing them. Also provided are methods for purifying and assaying ibandronic acid in any crystalline form (or amorphous).
    Type: Application
    Filed: September 22, 2006
    Publication date: July 12, 2007
    Inventors: Thomas Bayer, Ben-Zion Dolitzky, Revital Lifshitz-Liron, Inna Perutski, Michael Pinchasov
  • Processes for preparing cinacalcet hydrochloride crystal form I
    Publication number: 20070099998
    Abstract: The invention provides processes for the preparation of cinacalcet hydrochloride crystalline Form I.
    Type: Application
    Filed: May 23, 2006
    Publication date: May 3, 2007
    Inventors: Revital Lifshitz-Liron, Sharon Avhar-Maydan
  • Purification of cinacalcet
    Publication number: 20070060645
    Abstract: Isolated cinacalcet carbamate, processes for the preparation thereof, and processes for the use of cinacalcet carbamate as a reference marker and standard are provided. Also provided are cinacalcet salts substantially free of cinacalcet carbamate, and processes for the preparation thereof.
    Type: Application
    Filed: May 23, 2006
    Publication date: March 15, 2007
    Inventors: Revital Lifshitz-Liron, Yuriy Raizi, Revital Ramaty
  • Processes for preparing amorphous atorvastatin hemi-calcium
    Patent number: 7189861
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: March 13, 2007
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Limor Tessler, Judith Aronhime, Revital Lifshitz-Liron, Dalia Maidan-Hanoch, Nir Hasson
  • Amorphous cinacalcet hydrochloride and preparation thereof
    Publication number: 20070054963
    Abstract: Provided is amorphous cinacalcet hydrochloride, processes for the preparation thereof, and pharmaceutical compositions therewith.
    Type: Application
    Filed: May 23, 2006
    Publication date: March 8, 2007
    Inventors: Revital Lifshitz-Liron, Michael Pinchasov, Shlomit Wizel, Sharon Avhar-Maydan
  • Process for preparing Cinacalcet hydrochloride
    Publication number: 20070043243
    Abstract: Processes for preparing cinacalcet are provided.
    Type: Application
    Filed: May 16, 2006
    Publication date: February 22, 2007
    Inventors: Revital Lifshitz-Liron, Amihai Eisenstadt, Shlomit Wizel, Sharon Avhar-Maydan, Yuriy Raizi, Revital Ramaty
  • Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
    Publication number: 20070027323
    Abstract: The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts, amorphous zoledronate sodium salt, processes for making the polymorphs and amorphous zoledronate sodium salt, and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
    Type: Application
    Filed: September 25, 2006
    Publication date: February 1, 2007
    Inventors: Judith Aronhime, Revital Lifshitz-Liron
  • Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
    Publication number: 20070021617
    Abstract: The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts, amorphous zoledronate sodium salt, processes for making the polymorphs and amorphous zoledronate sodium salt, and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
    Type: Application
    Filed: September 25, 2006
    Publication date: January 25, 2007
    Inventors: Judith Aronhime, Revital Lifshitz-Liron
  • Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
    Publication number: 20070021389
    Abstract: The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts, amorphous zoledronate sodium salt, processes for making the polymorphs and amorphous zoledronate sodium salt, and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
    Type: Application
    Filed: September 25, 2006
    Publication date: January 25, 2007
    Inventors: Judith Aronhime, Revital Lifshitz-Liron
  • Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
    Publication number: 20070021619
    Abstract: The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts, amorphous zoledronate sodium salt, processes for making the polymorphs and amorphous zoledronate sodium salt, and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
    Type: Application
    Filed: September 25, 2006
    Publication date: January 25, 2007
    Inventors: Judith Aronhime, Revital Lifshitz-Liron
  • Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
    Publication number: 20070021618
    Abstract: The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts, amorphous zoledronate sodium salt, processes for making the polymorphs and amorphous zoledronate sodium salt, and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
    Type: Application
    Filed: September 25, 2006
    Publication date: January 25, 2007
    Inventors: Judith Aronhime, Revital Lifshitz-Liron
  • Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
    Publication number: 20070021616
    Abstract: The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts, amorphous zoledronate sodium salt, processes for making the polymorphs and amorphous zoledronate sodium salt, and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
    Type: Application
    Filed: September 25, 2006
    Publication date: January 25, 2007
    Inventors: Judith Aronhime, Revital Lifshitz-Liron
  • Processes for preparing amorphous atorvastatin hemi-calcium
    Patent number: 7161012
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: January 9, 2007
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Limor Tessler, Judith Aronhime, Revital Lifshitz-Liron, Dalia Maidan-Hanoch, Nir Hasson
  • Processes for preparing amorphous atorvastatin hemi-calcium
    Patent number: 7151183
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: December 19, 2006
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Limor Tessler, Judith Aronhime, Revital Lifshitz-Liron, Dalia Maidan-Hanoch, Nir Hasson
  • Polymorphs of clopidogrel hydrogensulfate
    Patent number: 7074928
    Abstract: Provided are new crystalline Forms III, IV, V and VI of clopidogrel hydrogensulfate and the amorphous form of clopidogrel hydrogensulfate, as well as their pharmaceutical compositions, and method of treatments with such compositions. Also provided are novel processes for preparation of clopidogrel hydrogensulfate Form I, Form II, Form III, Form IV, Form V, Form VI and amorphous form.
    Type: Grant
    Filed: January 8, 2003
    Date of Patent: July 11, 2006
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Revital Lifshitz-Liron, Eti Kovalevski-Ishai, Shlomit Wizel, Sharon Avhar-Maydan, Rami Lidor-Hadas
  • Novel process for making bisphosphonic acids using diluents other than halogenated hydrocarbons
    Publication number: 20060128960
    Abstract: Provided is a novel method of making bisphosphonic acids, e.g. risedronic acid, including the step of combining a carboxylic acid, phoshorous acid, and a halophosphorous compound in the presence of a diluent that is an aromatic hydrocarbon or a silicone fluid. When the diluent is an aromatic hydrocarbon, a inert support or ortho-phosphoric acid codiluent is advantageously included.
    Type: Application
    Filed: February 8, 2006
    Publication date: June 15, 2006
    Inventors: Rami Lidor-Hadas, Zvi Harel, Revital Lifshitz-Liron, Eti Kovalevski-Ishai
  • Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
    Publication number: 20060106232
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Application
    Filed: October 24, 2005
    Publication date: May 18, 2006
    Inventors: Judith Aronhime, Ramy Lidor-Hadas, Valerie Niddam-Hildesheim, Revital Lifshitz-Liron, Shlomit Wizel
  • Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
    Publication number: 20060106231
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Application
    Filed: October 24, 2005
    Publication date: May 18, 2006
    Inventors: Judith Aronhime, Ramy Lidor-Hadas, Valerie Niddam-Hildesheim, Revital Lifshitz-Liron, Shlomit Wizel